U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07215988) titled 'Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study' on Oct. 09.
Brief Summary: This study evaluates the time spent on obtaining insurance approval and drugs, means of insurance coverage, out-of-pocket costs for patients, and the surgical outcomes after neoadjuvant treatment is completed in skin cancer patients receiving "off label" and "on label" neoadjuvant treatment. "Neoadjuvant therapy" means cancer treatment given before surgery. However, in many instances, neoadjuvant therapy is used as an "off-label" approach for several types of skin cancers. "Off-label" means that the FD...